on 26 Oct 2021
Last Applicant/ Owned by
-69006 LYON
R
Serial Number
79299550 filed on 15th Jul 2020
Registration Number
6532856 registered on 26th Oct 2021
Correspondent Address
John R. RudolphEli Lilly and Company
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
Scientific research; biological and chemical research; biochemical research and development; research and development in the pharmaceutical, biomedical and biotechnological fields, namely, research into antibodies, including conjugated antibodies; research and development in the fields of biological development and biomanufacturing; laboratory research, analysis, evaluation, development and clinicRead More
Medical services; medical services, namely, medical modification of antibodies; medical services in the field of personalized medicine; medical advice and information services in the field of biopharmaceutical products; pharmaceutical advice; consultancy services in the field of medicine
Scientific research; biological and chemical research; biochemical research and development; research and development in the pharmaceutical, biomedical and biotechnological fields, namely, research into antibodies, including conjugated antibodies; research and development in the fields of biological development and biomanufacturing; laboratory research, analysis, evaluation, development and clinical testing of therapeutic, preventive and diagnostic compositions and treatments; conducting scientific and medical research for third parties in the field of pharmaceuticals and cancer therapy ; consultancy in the field of pharmaceutical research, chemistry, biotechnology; Performance of chemical analyses, namely, custom synthesis of chemical substances; chemical and biological development services, namely custom design and development of chemical reagents and biochemical assays; services of a chemist and a biologist; scientific laboratory services namely chemical and biological laboratory services; scientific laboratory services, namely, laboratory services concerning the modification and production of reagents, antibodies and conjugated antibodies; scientific research and development services in the field of reagent development and production of antibodies and conjugated antibodies; conducting chemical and biological analyses; customized design and development of chemical reagents, antibodies and conjugated antibodies; development of chemical substances, namely, chemical substances to tether molecules and in particular technological platforms for the creation or improvement of antibody-drug conjugates or any protein combined with a drug, a polynucleotide, another protein, a chemical entity or another functional entity intended for industry and science
Pharmaceutical preparations for the treatment of cancer ; pharmaceutical products for the prevention or treatment of human diseases, namely, the treatment of cancer; chemical, biological and biochemical products for medical and pharmaceutical use, namely, antibody-drug conjugates and any protein combined with a drug, a polynucleotide, another protein, a chemical entity, or another functional entity, and used as medical binders or fillers; pharmaceutical preparations, namely bioconjugates, intended for the diagnosis and treatment of diseases, namely, cancer ; antibody products, namely, antibody or protein bioconjugates for the medical diagnosis and treatment of cancer, namely, antibody/protein drug conjugates, antibody/protein labeled conjugates and antibody/protein imaging agent conjugates; delivery devices for antibodies, namely, drugs delivery agent in the form of antibodies drug conjugates that facilitate the delivery and action of medical preparations ; molecules and biomolecules, namely, reagents, antibody fragments, antibodies, all intended for medical diagnosis and disease treatment; pharmaceutical products, preparations and medical articles, namely, antibodies, antibody conjugates and active principles and antibody conjugates for medical purposes; chemical reagents for medical use, namely, chemical reagents to bind molecules for medical use; chemical reagents for the functionalization of biomolecules for medical use
Chemical, biochemical, biological and biotechnological preparations for use in industry and science ; chemical substances for the manufacture of pharmaceutical products for non-medical purposes, namely, for use in manufacturing of antibody conjugates ; chemical substances for tethering molecules, in particular chemical substances for tethering molecules for cancer therapy, for research in active substances and medicines other than for medical or veterinary purposes; chemical substances for the formation of antibody conjugates for use in laboratories, other than for medical or veterinary purposes ; chemical reagents for scientific purposes other than for medical or veterinary purposes; reagents for scientific or medical research; chemical, biochemical and biological reagents for scientific or medical research use; chemicals for bioconjugation, reversible cysteine protection, surface modification, and the production of prodrugs for use in laboratories, other than for medical or veterinary purposes; antibodies and antibody conjugates for scientific purposes, other than for medical or veterinary purposes; antibodies for scientific or medical research; molecules and biomolecules, namely, reagents, antibody fragments, antibodies, all intended for fundamental research and development, medical research and scientific diagnosis; iagnostic products for scientific or research use related to conjugated antibodies, namely, diagnostic preparations for scientific use
Preparation, transformation, processing of biopharmaceutical materials, reagents, antibodies and conjugated antibodies, namely, biomanufacturing for others, namely, manufacturing of pharmaceuticals using biological organisms in the manufacturing process; processing and transformation of biopharmaceuticals on behalf of third parties; custom manufacturing of scientific, medical, chemical, biochemical and pharmaceutical products, namely, conjugated antibodies and drug conjugate by biopharmaceutical compounders
No 79299550
No Service Mark
No
No
No
No
No
Yes
Yes
No
No
| Status Date | Action Taken |
|---|---|
| 28th Apr 2024 | NEW REPRESENTATIVE AT IB RECEIVE |
| 14th Mar 2024 | TEAS CHANGE O CORRESPONENCE RECEIVE |
| 14th Mar 2024 | APPLICANT/CORRESPONENCE CHANGES (NON-RESPONSIVE) ENTERE |
| 14th Mar 2024 | TEAS CHANGE O OWNER ARESS RECEIVE |
| 14th Mar 2024 | ATTORNEY/OM.REP.REVOKE AN/OR APPOINTE |
| 14th Mar 2024 | TEAS REVOKE/APP/CHANGE AR O ATTY/OM REP RECEIVE |
| 09th May 2022 | INAL ECISION TRANSACTION PROCESSE BY IB |
| 18th Apr 2022 | INAL ISPOSITION NOTICE SENT TO IB |
| 18th Apr 2022 | INAL ISPOSITION PROCESSE |
| 26th Jan 2022 | INAL ISPOSITION NOTICE CREATE, TO BE SENT TO IB |
